James S. J. Manuso, Ph.D., New Cortex CEO, to Present GLEN ROCK, NJ — September 8, 2015/Globe Newswire – Cortex Pharmaceuticals, Inc. (OTC: CORX) (“Cortex” or the “Company”), a leader in developing drugs for respiratory disorders, particularly obstructive sleep and central apneas and drug-induced respiratory depression, announces that it will be presenting at the Rodman &…
Dr. Arnold S. Lippa, Ph.D., to Continue as Executive Chairman of the Board of Directors and Chief Scientific Officer GLEN ROCK, NJ – (Marketwired – Aug 19, 2015) – Cortex Pharmaceuticals, Inc. (OTCQB: CORX) (“Cortex” or the “Company”), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today…
Cortex Announces Positive Phase 2 Data for Use of Dronabinol in the Treatment of Obstructive Sleep Apnea GLEN ROCK, N.J., July 1, 2014 (GLOBE NEWSWIRE) — Cortex Pharmaceuticals, Inc. (CORX) (“Cortex” or the “Company”), a biopharmaceutical company currently engaged in the development of drugs for respiratory disorders, announced today that it has entered into a…